Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-22

Clinical Trial Update: Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing etanercept, alone or with methotrexate, for psoriatic arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-02-22